AI English summary of an SEC filing — figures as filed
Jabil filed a resale prospectus supplement on January 27, 2025 to its previously filed automatic shelf registration statement (Form S-3, File No. 333-273111), registering the resale of up to 1,158,539 shares of common stock by a selling stockholder.
Key points
AI summaryJabil filed a resale prospectus supplement on January 27, 2025 to its previously filed automatic shelf registration statement (Form S-3, File No. 333-273111), registering the resale of up to 1,158,539 shares of common stock by a selling stockholder.
The company said the registered shares are issuable upon the exercise of a warrant issued under a Warrant Agreement dated December 27, 2024.
The company said it will not receive any proceeds from any sale of the shares by the selling stockholder.
The company said it filed this report to provide a legal opinion on the validity of the shares covered by the prospectus supplement, and it attached the opinion from Skadden, Arps, Slate, Meagher & Flom LLP as Exhibit 5.1.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Resale Prospectus Supplement Filed
Jabil filed a resale prospectus supplement on January 27, 2025 to its previously filed automatic shelf registration statement (Form S-3, File No. 333-273111), registering the resale of up to 1,158,539 shares of common stock by a selling stockholder.
Source · Based on the filing body and exhibits
Shares Issuable Upon Warrant Exercise
The company said the registered shares are issuable upon the exercise of a warrant issued under a Warrant Agreement dated December 27, 2024.
Source · Based on the filing body and exhibits
Company Will Not Receive Resale Proceeds
The company said it will not receive any proceeds from any sale of the shares by the selling stockholder.
Source · Based on the filing body and exhibits
Legal Opinion on Share Validity Attached
The company said it filed this report to provide a legal opinion on the validity of the shares covered by the prospectus supplement, and it attached the opinion from Skadden, Arps, Slate, Meagher & Flom LLP as Exhibit 5.1.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…